Condition
Recurrent Childhood Acute Myeloid Leukemia clinical trials and research
Research outlook What's coming for Acute myeloid leukemia: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Recurrent Childhood Acute Myeloid Leukemia clinical trials that are recruiting, in United States. By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Childhood Acute Myeloid Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| FH-FOLR1 CAR T-cell therapy for children with relapsed or refractory AML | Phase 1 | Seattle, Washington | Recruiting | Sep 24, 2024 |
| Finding the best dose of imetelstat with chemotherapy for children with certain blood cancers | Phase 1 | Birmingham, Alabama and 18 other locations | Recruiting | Feb 8, 2024 |
| Testing drug sensitivity and genetic profiling for pediatric cancer patients | Phase 1 | Miami, Florida | Recruiting | May 15, 2023 |
| HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant | Phase 1 | Seattle, Washington | Recruiting | Oct 31, 2017 |
All recruiting trials (4)
-
FH-FOLR1 CAR T-cell therapy for children with relapsed or refractory AML
This trial will test FH-FOLR1 CAR T cells in children aged six and under whose FOLR1-positive acute myeloid leukemia has returned or not responded to treatment.
-
Finding the best dose of imetelstat with chemotherapy for children with certain blood cancers
This study is testing the best dose of a new drug called imetelstat combined with chemotherapy to see if it can help children with tough blood cancers like leukemia and myelodysplastic syndrome.
-
Testing drug sensitivity and genetic profiling for pediatric cancer patients
This study is testing a new way to find the best cancer treatments for children by looking at how their tumor cells respond to different drugs and comparing those results to standard treatments.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
Related topics
Quick answers
How many Recurrent Childhood Acute Myeloid Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.